Skip to content

Amgen AMGN EV / sales

EV / sales at other companies

Eli Lilly logo
Eli LillyLLY
11.9×-4.0×
Pfizer logo
PfizerPFE
3.5×+0.3×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.5×+0.6×
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
10,042.9×+9,939×
Roivant Sciences logo
Roivant SciencesROIV
2,241.3×+1,993×
Merck & Co. logo
Merck & Co.MRK
5.2×+1.2×

Other financials

Income statement

See full
Revenue$8.6B+5.8%
Gross profit$5.9B+13.4%
Operating income$2.7B+126%
Net income$1.8B+5.1%
EPS (diluted)$3.34+4.4%

Balance sheet

See full
Cash & equivalents$559.0M+10.0%
Total debt$57.3B-0.1%
Total equity$9.2B+48.1%
Total assets$92.5B+3.5%

Cash flow

See full
Operating cash flow$2.2B+57.4%
CapEx$712.0M+73.2%
Free cash flow$1.5B+50.7%

Valuation

See full
Market cap$184.4B+13.3%
Enterprise value$241.16B+9.9%
P/E23.6×-3.8×
P/S+0.2×

Profitability

See full
Gross margin68.3%+5.3pp
Operating margin28.4%+6.6pp
Net margin21%+3.6pp

Returns & leverage

See full
Return on equity101.3%-4.4pp
Debt / equity6.2×-3.0×
Current ratio1.3×+0.1×

Where this comes from

Calculated from Amgen’s reported figures.

Based on the most recent quarter.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amgen's EV / sales?
Amgen (AMGN) reported EV / sales of 6.6× in Q1 2026.
How has Amgen's EV / sales changed year-over-year?
Amgen's EV / sales increased by 0.8% year-over-year, from 6.6× to 6.6×.
What is the long-term trend for Amgen's EV / sales?
Over 4 years (2021 to 2025), Amgen's EV / sales has grown at a -1.3% compound annual growth rate (CAGR), from 25.7× to 24.4×.
What does EV / sales mean?
What the whole business costs relative to its annual sales.
How do you interpret EV / sales?
A fallback valuation gauge for pre-profit or cyclical firms. Like P/S, only comparable across similar-margin businesses, but it accounts for debt and cash unlike P/S.
How does EV / sales compare across companies?
Compare within a margin cohort; the debt-and-cash adjustment makes it cleaner than P/S for leveraged firms.